Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)

HKG:2348 Revenue

Dawnrays Pharmaceutical (Holdings) had revenue of 577.45M CNY in the half year ending June 30, 2024, a decrease of -7.38%. This brings the company's revenue in the last twelve months to 1.08B, down -17.29% year-over-year. In the year 2023, Dawnrays Pharmaceutical (Holdings) had annual revenue of 1.15B, down -9.90%.

• Revenue (ttm): 1.08B CNY
• Revenue Growth: -17.29%
• P/S Ratio: 1.58
• Revenue / Employee: 943.72K CNY
• Employees: 1,143
• Market Cap: 1.83B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.15B	-126.54M	-9.90%
Dec 31, 2022	1.28B	112.53M	9.66%
Dec 31, 2021	1.17B	140.89M	13.75%
Dec 31, 2020	1.02B	74.26M	7.82%
Dec 31, 2019	950.01M	1.07M	0.11%